News
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild. Crispr Therapeutics rallied for a second day on ...
1d
Zacks.com on MSNCRISPR Therapeutics (CRSP) Moves 9.6% Higher: Will This Strength Last?CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest ...
Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...
11d
Zacks Investment Research on MSNCRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should KnowCRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
Get instant access to a free live CRSP US Total Market streaming chart. The chart is intuitive yet powerful, customize the chart type to view candlestick patterns, area, line graph style, bar ...
3d
Zacks Investment Research on MSNHere's Why CRISPR Therapeutics AG (CRSP) Fell More Than Broader MarketCRISPR Therapeutics AG (CRSP) ended the recent trading session at $51.19, demonstrating a -1.88% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.79%.
Explore more
Vanguard’s announcement on Tuesday that they were dumping MSCI indexes in favor of CRSP indexes for most U.S. index funds will require some reshuffling among several size and style indexes. The ...
Heaton: CRSP itself is unique, so we have a unique opportunity because we have CRSP, an academic data provider—the first, the biggest, the most well-known, the most respected. CRSP data has a long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results